Paper39286288
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment.
Gao F and 4 others. Drug Des Devel Ther, 2024. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment. Papers, record 39286288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39286288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cardiotoxicity | Major topic |
| Humans | |
| Animals | |
| Neoplasms |
Source PubMed
References228
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27145188 | Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer. | Am J Ther | 2017 | https://conductscience.org/library/papers/27145188 | PubMed |
| 2 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 3 | 32958254 | Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32958254 | PubMed |
| 4 | 36396497 | Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. | Trends Pharmacol Sci | 2023 | https://conductscience.org/library/papers/36396497 | PubMed |
| 5 | 22147501 | Doxorubicin- and daunorubicin-induced regulation of Ca2+ and H+ fluxes through human bax inhibitor-1 reconstituted into membranes. | J Pharm Sci | 2012 | https://conductscience.org/library/papers/22147501 | PubMed |
| 6 | 22471377 | CD28-specific immunomodulating antibodies: what can be learned from experimental models? | Am J Transplant | 2012 | https://conductscience.org/library/papers/22471377 | PubMed |
| 7 | 25766524 | SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways. | Cell Physiol Biochem | 2015 | https://conductscience.org/library/papers/25766524 | PubMed |
| 8 | 38324115 | Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/38324115 | PubMed |
| 9 | 30849371 | VEGF in Signaling and Disease: Beyond Discovery and Development. | Cell | 2019 | https://conductscience.org/library/papers/30849371 | PubMed |
| 10 | 17652818 | Long-term and short-term models for studying anthracycline cardiotoxicity and protectors. | Cardiovasc Toxicol | 2007 | https://conductscience.org/library/papers/17652818 | PubMed |
| 11 | 32339784 | Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32339784 | PubMed |
| 12 | 35690107 | Mitotherapy in doxorubicin induced cardiotoxicity: A promising strategy to reduce the complications of treatment. | Life Sci | 2022 | https://conductscience.org/library/papers/35690107 | PubMed |
| 13 | 29931399 | Tyrosine Kinase Inhibitor-Induced Hypertension. | Curr Oncol Rep | 2018 | https://conductscience.org/library/papers/29931399 | PubMed |
| 14 | 29966675 | Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? | Toxicol Appl Pharmacol | 2018 | https://conductscience.org/library/papers/29966675 | PubMed |
| 15 | 31774307 | Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle. | Am J Physiol Regul Integr Comp Physiol | 2020 | https://conductscience.org/library/papers/31774307 | PubMed |
| 16 | 32127639 | European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. | Leukemia | 2020 | https://conductscience.org/library/papers/32127639 | PubMed |
| 17 | 30482794 | Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin. | Blood | 2019 | https://conductscience.org/library/papers/30482794 | PubMed |
| 18 | 19406633 | Angiogenesis in pre-malignant conditions. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19406633 | PubMed |
| 19 | 7993841 | A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party. | Ann Oncol | 1994 | https://conductscience.org/library/papers/7993841 | PubMed |
| 20 | 18521186 | Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18521186 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42949492 | Synergistic Promotion of Ferroptosis in Cardiomyocytes by Tumor Cell Secretory Factors and PD-1 Blockade. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42949492 | PubMed |
| 42814216 | Dexpanthenol Attenuates Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42814216 | PubMed |
| 42738801 | Cardiovascular Toxicity in Cancer Therapy: Potential Mechanisms of Ferroptosis and Treatment Strategies. | Cells | 2026 | https://conductscience.org/library/papers/42738801 | PubMed |
| 42542771 | The Multitalented Marvels: Exploring the Versatile Potential of Natural Products in Osteosarcoma Treatment. | Cancer Inform | 2026 | https://conductscience.org/library/papers/42542771 | PubMed |
| 42415091 | Metabolic regulation of macrophage polarization in myocardial infarction: from mechanisms to targeted therapies. | J Transl Med | 2026 | https://conductscience.org/library/papers/42415091 | PubMed |
| 42346633 | Cardiovascular Imaging for the Early Detection of Cardiotoxicity from Emerging Cancer Therapies: Mechanistic Insights Across the Pediatric and Adult Spectrum. | J Pers Med | 2026 | https://conductscience.org/library/papers/42346633 | PubMed |
| 42335316 | Cardiac Implantable Electronic Devices in Oncology Patients: Challenges and Management. | J Cardiovasc Electrophysiol | 2026 | https://conductscience.org/library/papers/42335316 | PubMed |
| 42200068 | Mitochondrial-targeted therapeutics in oral squamous cell carcinoma: molecular and therapeutic implications. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42200068 | PubMed |
| 42074235 | SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074235 | PubMed |
| 41995108 | Ponatinib confers adult human cardiomyocyte toxicity via inhibition of AKT signaling. | Physiol Rep | 2026 | https://conductscience.org/library/papers/41995108 | PubMed |
| 41938665 | Protective Effect of Silymarin Against Paclitaxel-Induced Cardiotoxicity. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/41938665 | PubMed |
| 41789315 | Precision Monitoring Strategies for Chemotherapy-Induced Cardiotoxicity: A Review of Molecular Indicators for Early Detection and Risk Stratification. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41789315 | PubMed |
| 41766769 | Frailty Meets Cardio-oncology: A New Frontier in Personalised Cancer Care. | Eur Cardiol | 2026 | https://conductscience.org/library/papers/41766769 | PubMed |
| 41742616 | Cardioprotective Potential of Hedyotis corymbosa in Drug-induced Cardiotoxicity: Insights from Network Pharmacology and Preclinical Studies. | Curr Drug Targets | 2026 | https://conductscience.org/library/papers/41742616 | PubMed |
| 41639402 | Cancer treatment-related cardiotoxicity, molecular mechanism, challenges, and research trends. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41639402 | PubMed |
| 41567388 | Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41567388 | PubMed |
| 41552683 | Anthracycline-induced cardiotoxicity associated with myocardial energy metabolism: mechanisms revealed through an integration of 18F-FDG PET/CT and data-independent acquisition proteomics. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41552683 | PubMed |
| 41533158 | The association between colorectal cancer drugs and heart failure: a real-world pharmacovigilance study of the FAERS database. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41533158 | PubMed |
| 41471707 | Synthetic Flozins in Cancer Prevention and Combination Strategies: Structural Insights and Therapeutic Potential. | Molecules | 2025 | https://conductscience.org/library/papers/41471707 | PubMed |
| 41471396 | Bassia indica Attenuates Cardiotoxicity in a Rat Model via Anti-Inflammatory, Antioxidant, and Keap1/Nrf2 Modulation. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471396 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39286288
GET https://conductscience.org/api/papers/v1/39286288/references?page=2